I recently saw this statement in big bold letters on the last page of a report issued by one of our competitors. I agree, independence can be a real game-changer. But what is “independence” in this context? (more…)
With 20 years now under our belt, I can’t help but feel so grateful for where we are as a firm, where we’ve been, and where we’re going. (more…)
If recent events have taught us anything, it is to be prepared for the unexpected. While none of us could have fully predicted the dramatic impact of COVID-19 on our families, organizations, and the world economy, hindsight reveals safeguards we might have put in place to lessen the damage.
Ironically, this is a subject I had been wrestling with well before the coronavirus was receiving any attention from the international media. Those of you who follow our firm’s work know we have long been concerned about the growing economic threat posed by rising specialty drug costs to employer-funded health plans and their members. It actually dates back to 2005, when I first learned about a $125,000 oncology drug that didn’t save lives. On average, it only extended life by less than two months of sub-optimal living. (more…)